Pfizer and Allergan to merge in $160-billion pharmaceutical deal that … | Business News

Pfizer and Allergan to merge in $160-billion pharmaceutical deal that …

23 Nov 2015 | Author: | No comments yet »

Pfizer secures Allergan takeover deal to create new drugs giant.

Viagra’s manufacturer, the New York-based Pfizer will keep its name – and crucially, may be able to escape the US corporate tax rate of 35 percent – one of the highest in the world.

Instead, by shifting its headquarters to Dublin under a so-called “inversion” deal, the home of Botox maker Allergan, it may see its tax liability plunge.

Here you can write a commentary on the recording "Pfizer and Allergan to merge in $160-billion pharmaceutical deal that …".

* Required fields
All the reviews are moderated.
Twitter-news
Our partners
Follow us
Contact us
Our contacts

About this site